Menu
Back to Journals » Cancer Management and Research » Volume 13
Original Research
Cost-Effectiveness Analysis of Dacomitinib versus Gefitinib in the First-Line Treatment of EGFR-Positive Advanced or Metastatic Non-Small Cell Lung Cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,988 | Dovepress* | 3,540+ | 500 | 4,040 | |
| PubMed Central* | 448 | 185 | 633 | ||
| Totals | 3,988 | 685 | 4,673 | ||
| *Since 28 May 2021 | |||||
View citations on PubMed Central and Google Scholar